Exhibit 107

Calculation of Filing Fee Tables

Form F-3

(Form Type)

Ambrx Biopharma Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

	Security Type		Security Class Title	Fee Calculation Rule	Amount Registered	Proposed Maximum Offering Price Per Unit	Maximum Offering Price	Fee Rate	Amount of Registration Fee
Fees to Be Paid		Equity	Ordinary shares, par value $0.0001 per share (1)	457(o)	(2)	(3)	$300,000,000 (4)	0.0000927	$27,810
			Total Offering Amounts				$300,000,000		$27,810
			Total Fees Previously Paid
			Total Fee Offsets
			Net Fee Due						$27,810

(1) These ordinary shares offered in the United States will be represented by American Depositary Shares, or ADSs, each of which represents seven ordinary shares of the registrant.

(2) There are being registered hereunder such indeterminate number of ordinary shares, including ADSs representing ordinary shares as shall have an aggregate initial offering price not to exceed $300,000,000. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, the Securities Act, the shares being registered hereunder also include such indeterminate number of shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.

(3) The proposed maximum per unit and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified pursuant to Instruction 2.A.ii.b. to the Calculation of Filing Fee Tables and Related Disclosure on of Item 9(b) of Form F-3 under the Securities Act.

(4) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. In no event will the aggregate offering price of all securities sold by the registrant from time to time pursuant to this registration statement exceed $300,000,000.